MLTX

MoonLake ImmunotherapeuticsNASDAQHealthcare

$17.36+5.08%ClosedMarket Cap: $1.25B

As of 2026-04-06

Recent Analyst Ratings

Date	Firm	Action	Rating	Previous
2026-03-30	BTIG	—	Buy	—
2026-03-23	Wolfe Research	—	Outperform	—
2026-03-19	Rothschild & Co	—	Buy	—
2026-03-11	Clear Street	—	Buy	—
2026-03-02	RBC Capital	—	Sector Perform	—
2026-03-02	HC Wainwright & Co.	—	Buy	—
2026-02-26	Needham	—	Buy	—
2026-02-24	Oppenheimer	—	Outperform	—
2026-02-23	BTIG	—	Buy	—
2026-01-15	Goldman Sachs	—	Sell	—

Forward Estimates

Period	EPS Est.	Revenue Est.	# Analysts
Fri Dec 31	$-3.63	$22.1M	9
Sun Dec 31	$-2.59	$137.9M	8
Mon Dec 31	$-0.48	$452.9M	6
Tue Dec 31	$2.74	$897.3M	6